BioSante jumps as its drug boosts efficacy of swine flu vaccine

(Reuters) - BioSante Pharmaceuticals Inc. said its adjuvant, BioVant, increases the efficacy of vaccines for multiple flu strains, including a potential new vaccine against H1N1 virus, or swine flu, sending its shares up almost 28 percent in early trade. An adjuvant is an ingredient that ...

Copyright CRAIN - Crain's
Contact Us